Ironwood Pharma (IRWD) PT Cut To $18 At Mizuho On Pipeline Delays
Tweet Send to a Friend
Mizuho Securities analyst, Irina Koffler, reiterated her Buy on Ironwood Pharmaceuticals (NASDAQ: IRWD) but cut her price target to $18 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
